Tender detail
Open-house pharmaceutical rebate agreements for apixaban
Summary
AOK Bayern is offering interested pharmaceutical companies non-exclusive rebate agreements for medicines containing the active ingredient apixaban (ATC B01AF02). Agreements may start no earlier than 1 December 2026 and run until 30 November 2028.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.